Matthew R. Patterson

Insider Reports History

Entity
Individual
Location
C/O Amicus Therapeutics, Inc., 6 Cedar Brook Drive, Cranbury, NJ
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew R. Patterson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Director Option (Right to Buy) 23K $309K $13.42 Jun 14, 2023 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 23, 2024 Direct

Insider Reports Filed by Matthew R. Patterson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
FIXX Homology Medicines, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
FIXX Homology Medicines, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
FIXX Homology Medicines, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director